BOE Varitronix Limited - 0710.HK

0710.HK Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
0710.HK	3.0	13.2	12.1	20.2	51.7	18.3	-38.9	168.0	29.6	-66.1
S&P 500	1.0	3.7	2.2	2.3	8.9	23.9	32.3	80.6	196.5	33856.2

Compare 0710.HK with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	0710.HK
name	BOE Varitronix Limited
price	6.78
changes percentage	3.0395
change	0.2
day low	6.56
day high	7.14
year high	7.19
year low	4.02
market cap	5366878500
price avg 50	6.1136
price avg 200	5.2545
exchange	HKSE
volume	8870000
avg volume	2032630
open	6.56
previous close	6.58
eps	0.56
pe	12.11
earnings announcement	2025-03-20T12:00:00.000+0000
shares outstanding	791575000
timestamp	2025-01-17 08:08:13

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 58.7%

Overall Quarterly Financial Health: 45.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	10760416000	10722361000	0.35
gross profit	1965500000	881452000	122.98
gross profit ratio	0.18	0.08	122.20
research and development expenses	236522000	190165000	24.38
operating expenses	1432416000	352802000	306.01
interest income	93282000	52849000	76.51
interest expense	28607000	14041000	103.74
ebitda	778373000	843212000	-7.69
ebitdaratio	0.07	0.07	10.85
operating income	569723000	528650000	7.77
operating income ratio	0.05	0.05	7.39
net income	475260000	582451000	-18.40
net income ratio	0.04	0.05	-18.69
eps	0.6	0.78	-23.08

Overall Score of Annual Income Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 10,760 million in 2023 from 10,722 million in 2022 representing a change of 0.35%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 1,966 million in 2023 from 881 million in 2022 representing a change of 122.98%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 237 million in 2023 from 190 million in 2022 representing a change of 24.38%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 1,432 million in 2023 from 353 million in 2022 representing a change of 306.01%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Operating Income: Operating income increased to 570 million in 2023 from 529 million in 2022 representing a change of 7.77%. The increase in operating income indicates better operational performance and increased profitability.

• 📉 Negative Indicators

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 778 million in 2023 from 843 million in 2022 representing a change of -7.69%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 475 million in 2023 from 582 million in 2022 representing a change of -18.4%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.6 in 2023 from 0.6 in 2022 representing a change of -23.08%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
revenue	6157319000	5550199000	10.94
gross profit	362728000	516458000	-29.77
gross profit ratio	0.06	0.09	-36.69
research and development expenses	138000000	124522000	10.82
operating expenses	261047000	240842000	8.39
interest income	58067000	45217000	28.42
interest expense	8540000	11964000	-28.62
ebitda	317352000	449360000	-29.38
ebitdaratio	0.05	0.07	-27.34
operating income	101681000	275616000	-63.11
operating income ratio	0.02	0.05	-66.75
net income	172100000	272748000	-36.90
net income ratio	0.03	0.05	-43.12
eps	0.22	0.34	-35.29

Overall Score of Quarterly Income Statement

0.25 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 6,157 million in 2024Q2 from 5,550 million in 2023Q4 representing a change of 10.94%. This indicates a sales growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 138 million in 2024Q2 from 125 million in 2023Q4 representing a change of 10.82%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 363 million in 2024Q2 from 516 million in 2023Q4 representing a change of -29.77%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 261 million in 2024Q2 from 241 million in 2023Q4 representing a change of 8.39%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 317 million in 2024Q2 from 449 million in 2023Q4 representing a change of -29.38%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 102 million in 2024Q2 from 276 million in 2023Q4 representing a change of -63.11%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 172 million in 2024Q2 from 273 million in 2023Q4 representing a change of -36.9%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.22 in 2024Q2 from 0.22 in 2023Q4 representing a change of -35.29%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	10033870000	8283100000	21.14
total liabilities	5624159000	4148416000	35.57
total equity	4409711000	4115773000	7.14
cash and cash equivalents	3500760000	2818823000	24.19
short term investments	15405000	61788000	-75.07
long term investments	41897000	50510000	-17.05
total current assets	8097225000	6587117000	22.93
total non current assets	1936645000	1695983000	14.19
total current liabilities	5022791000	4103125000	22.41
total non current liabilities	601368000	45291000	1227.79
common stock	197894000	197853000	0.02
retained earnings	1787999000	1302272000	37.30
total debt	642002000	678994000	-5.45

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 10,034 million in 2023 from 8,283 million in 2022 representing a change of 21.14%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 4,410 million in 2023 from 4,116 million in 2022 representing a change of 7.14%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 3,501 million in 2023 from 2,819 million in 2022 representing a change of 24.19%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 8,097 million in 2023 from 6,587 million in 2022 representing a change of 22.93%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 198 in 2023 from 198 in 2022 representing a change of 0.02%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 1,788 million in 2023 from 1,302 million in 2022 representing a change of 37.3%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 642 million in 2023 from 679 million in 2022 representing a change of -5.45%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 5,624 million in 2023 from 4,148 million in 2022 representing a change of 35.57%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 15 million in 2023 from 62 million in 2022 representing a change of -75.07%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 5,023 million in 2023 from 4,103 million in 2022 representing a change of 22.41%. This indicates a higher short-term debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
total assets	10808428000	10033870000	7.72
total liabilities	6391606000	5624159000	13.65
total equity	4416822000	4409711000	0.16
cash and cash equivalents	3115999000	3556644000	-12.39
short term investments	827572000	15405000	5272.10
long term investments	41883000	41897000	-0.03
total current assets	8572254999	8097225000	5.87
total non current assets	2236173000	1936645000	15.47
total current liabilities	5753095000	5022791000	14.54
total non current liabilities	638510999	601367999	6.18
common stock	197894000	197894000	0.00
retained earnings	1964960000	1787999000	9.90
total debt	635839000	642002000	-0.96

Overall Score of Quarterly Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 10,808 million in 2024Q2 from 10,034 million in 2023Q4 representing a change of 7.72%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 4,417 million in 2024Q2 from 4,410 million in 2023Q4 representing a change of 0.16%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 828 million in 2024Q2 from 15 million in 2023Q4 representing a change of 5272.1%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 8,572 million in 2024Q2 from 8,097 million in 2023Q4 representing a change of 5.87%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 1,965 million in 2024Q2 from 1,788 million in 2023Q4 representing a change of 9.9%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 636 million in 2024Q2 from 642 million in 2023Q4 representing a change of -0.96%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 6,392 million in 2024Q2 from 5,624 million in 2023Q4 representing a change of 13.65%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 3,116 million in 2024Q2 from 3,557 million in 2023Q4 representing a change of -12.39%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 5,753 million in 2024Q2 from 5,023 million in 2023Q4 representing a change of 14.54%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	681937000	551705000	23.61
operating cash flow	1186078000	811831000	46.10
free cash flow	677894000	-368825000	283.80
capital expenditure	-508184000	-1180656000	56.96
depreciation and amortization	205263000	171068000	19.99
deferred income tax	0	-558585000	100.00
stock based compensation	20385000	22590000	-9.76
accounts payables	1309178000	1164944000	12.38
inventory	-398345000	-818948000	51.36
acquisitions net	0	-278612000	100.00
investments in property plant and equipment	-502059000	-1180656000	57.48
net cash used for investing activites	-224103000	-1486253000	84.92
debt repayment	-47264000	693677000	-106.81
common stock issued	330000	804111000	-99.96
common stock repurchased	0	0	NaN
dividends paid	-180964000	-109284000	-65.59
net cash used provided by financing activities	-263466999	1376695000	-119.14
cash at end of period	3500760000	2818823000	24.19
accounts receivables	-347096000	-539855000	35.71
cash at beginning of period	2818823000	2267118000	24.34

Overall Score of Annual Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 682 million in 2023 from 552 million in 2022 representing a change of 23.61%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 1,186 million in 2023 from 812 million in 2022 representing a change of 46.1%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 678 million in 2023 from -369 million in 2022 representing a change of 283.8%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 20 million in 2023 from 23 million in 2022 representing a change of -9.76%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -508 million in 2023 from -1,181 million in 2022 representing a change of 56.96%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from -559 million in 2022 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Accounts Payables: The absolute value of Accounts Payables increased to 1,309 million in 2023 from 1,165 million in 2022 representing a change of 12.38%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to -347 in 2023 from -540 million in 2022 representing a change of 35.71%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -181 million in 2023 from -109 million in 2022 representing a change of -65.59%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2023Q4	Q/Q change %
0000000000
operating cash flow	846035000	1566275000	-45.98
free cash flow	409983000	1437303000	-71.48
capital expenditure	-436052000	-128972000	-238.10
depreciation and amortization	120901000	114944000	5.18
deferred income tax	0	0	NaN
stock based compensation	0	20385000	-100.00
accounts receivables	0	-347096000	100.00
accounts payables	0	0	NaN
inventory	0	-398345000	100.00
acquisitions net	668000	1256000	-46.82
investments in property plant and equipment	-440345000	-128972000	-241.43
net cash used for investing activites	-1249997000	-80966000	-1443.85
debt repayment	-8068000	0	NaN
common stock issued	0	0	NaN
common stock repurchased	-4731000	0	NaN
dividends paid	0	-180964000	100.00
net cash used provided by financing activities	-20925000	-360420000	94.19
net change in cash	-440645000	1200578000	-136.70
cash at end of period	3115999000	3556644000	-12.39
cash at beginning of period	3556644000	2356066000	50.96

Overall Score of Quarterly Cashflow Statement

0.43 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -441 million in 2024Q2 from 1,201 million in 2023Q4 representing a change of -136.7%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 846 million in 2024Q2 from 1,566 million in 2023Q4 representing a change of -45.98%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 410 million in 2024Q2 from 1,437 million in 2023Q4 representing a change of -71.48%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024Q2 from -347 million in 2023Q4 representing a change of 100.0%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Capital Expenditure: Capital Expenditure decreased to -436 million in 2024Q2 from -129 million in 2023Q4 representing a change of -238.1%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q2 from 20 million in 2023Q4 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Dividends Paid: Dividends Paid increased to 0 million in 2024Q2 from -181 million in 2023Q4 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	13.68	14.44	-5.21
net income per share	0.6	0.78	-22.93
operating cash flow per share	1.51	1.09	38.00
free cash flow per share	0.86	-0.5	273.61
cash per share	4.47	3.88	15.29
book value per share	5.61	5.57	0.74
tangible book value per share	5.58	5.54	0.70
shareholders equity per share	5.54	5.47	1.17
interest debt per share	0.85	0.93	-8.60
market cap	5551737613.06	11022505347	-49.63
enterprise value	2692979613.06	8882676347	-69.68
pe ratio	11.68	18.92	-38.27
price to sales ratio	0.52	1.03	-49.81
pocfratio	4.68	13.58	-65.53
pfcf ratio	8.19	-29.89	127.40
pb ratio	1.28	2.71	-52.97
ptb ratio	1.28	2.71	-52.97
ev to sales	0.25	0.83	-69.79
enterprise value over ebitda	3.46	10.53	-67.16
ev to operating cash flow	2.27	10.94	-79.25
ev to free cash flow	3.97	-24.08	116.49
earnings yield	0.09	0.05	62.00
free cash flow yield	0.12	-0.03	464.92
debt to equity	0.15	0.17	-11.72
debt to assets	0.06	0.08	-21.95
net debt to ebitda	-3.67	-2.54	-44.73
current ratio	1.61	1.61	0.42
interest coverage	19.92	37.65	-47.10
income quality	2.2	1.39	57.58
dividend yield	0.03	0.01	228.77
payout ratio	0.38	0.19	102.94
sales general and administrative to revenue	0.0	0.0	7.53
research and ddevelopement to revenue	0.02	0.02	23.94
intangibles to total assets	0.0	0.0	-6.70
capex to operating cash flow	0.43	1.45	-70.54
capex to revenue	0.05	0.11	-57.11
capex to depreciation	2.48	6.9	-64.13
stock based compensation to revenue	0.0	0.0	-10.08
graham number	8.68	9.83	-11.70
roic	0.1	0.09	3.54
return on tangible assets	0.05	0.07	-32.65
graham net net	-1.44	1.45	-199.79
working capital	3074434000	2483992000	23.77
tangible asset value	4384650000	4112511000	6.62
net current asset value	2473066000	2438701000	1.41
invested capital	4859075000	3996465000	21.58
average receivables	1038400500	1862190500	-44.24
average payables	3374139000	2295978000	46.96
average inventory	1757551000	1200309000	46.42
days sales outstanding	0	70.7	-100.00
days payables outstanding	158.04	109.05	44.93
days of inventory on hand	80.81	58.16	38.95
receivables turnover	0	5.16	-100.00
payables turnover	2.31	3.35	-31.00
inventory turnover	4.52	6.28	-28.03
roe	0.11	0.14	-23.82
capex per share	0.65	1.59	-59.34

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 11.68 on 2023-12-31 from 18.92 on 2022-12-31, representing a change of -38.27%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.61 on 2023-12-31 from 1.61 on 2022-12-31, representing a change of 0.42%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.15 on 2023-12-31 from 0.17 on 2022-12-31, representing a change of -11.72%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2024-06-30 Q2	2023-12-31 Q4	Q/Q change %
0710.HK
calendar year	2024	2023	NaN
revenue per share	7.82	7.01	11.52
net income per share	0.22	0.34	-36.57
operating cash flow per share	1.07	1.98	-45.70
free cash flow per share	0.52	1.82	-71.33
cash per share	5.01	4.51	10.98
book value per share	5.61	5.57	0.69
tangible book value per share	5.57	5.54	0.64
shareholders equity per share	5.53	5.5	0.61
interest debt per share	0.82	0.83	-0.95
market cap	3748193903.44	5588520940.24	-32.93
enterprise value	1268033903.44	2673878940.24	-52.58
pe ratio	5.44	5.12	6.29
price to sales ratio	0.61	1.01	-39.54
pocfratio	4.43	3.57	24.17
pfcf ratio	9.14	3.89	135.13
pb ratio	0.86	1.28	-32.99
ptb ratio	0.86	1.28	-32.99
ev to sales	0.21	0.48	-57.25
enterprise value over ebitda	4.0	5.95	-32.85
ev to operating cash flow	1.5	1.71	-12.21
ev to free cash flow	3.09	1.86	66.25
earnings yield	0.05	0.05	-5.92
free cash flow yield	0.11	0.26	-57.47
debt to equity	0.15	0.15	-1.05
debt to assets	0.06	0.06	-8.06
net debt to ebitda	-7.82	-6.49	-20.49
current ratio	1.49	1.61	-7.57
interest coverage	11.91	23.04	-48.32
income quality	4.92	5.74	-14.39
dividend yield	0	0.03	-100.00
payout ratio	0	0.66	-100.00
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.02	0.02	-0.10
intangibles to total assets	0.0	0.0	1.46
capex to operating cash flow	0.52	0.08	525.93
capex to revenue	0.07	0.02	204.76
capex to depreciation	3.61	1.12	221.44
stock based compensation to revenue	0	0.0	-100.00
graham number	5.22	6.53	-20.11
roic	0.02	0.05	-59.90
return on tangible assets	0.02	0.03	-41.42
graham net net	0.45	0.98	-53.72
working capital	2819159999	3074434000	-8.30
tangible asset value	4389430999	4384650000	0.11
net current asset value	2180648999	2473066000	-11.82
invested capital	4903723999	4859075000	0.92
average receivables	None	None	NaN
average payables	None	None	NaN
average inventory	None	None	NaN
days sales outstanding	37.09	40.06	-7.41
days payables outstanding	65.87	68.09	-3.26
days of inventory on hand	28.0	34.81	-19.57
receivables turnover	2.43	2.25	8.01
payables turnover	1.37	1.32	3.37
inventory turnover	3.21	2.59	24.33
roe	0.04	0.06	-36.96
capex per share	0.55	0.16	239.88

• Negative

  ROE: Return on Equity (ROE) decreased to 0.04 on 2024-06-30 Q2 from 0.06 on 2023-12-31 Q4, representing a change of -36.96%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 5.44 on 2024-06-30 Q2 from 5.12 on 2023-12-31 Q4, representing a change of 6.29%. Indicating an increase in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.15 on 2024-06-30 Q2 from 0.15 on 2023-12-31 Q4, representing a change of -1.05%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Neutral

  Current Ratio: Current Ratio decreased to 1.49 on 2024-06-30 Q2 from 1.61 on 2023-12-31 Q4, representing a change of -7.57%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None